As seen in other glioneuronal tumors, BRAF V600E mutations and FGFR1 alterations (including FGFR1 germline mutations) have been reported in up to 30%–80% of the tumors depending on the composition of the tumor cohort analyzed [57,58]. The gene discussed is BRAF; the disease is neoplasm.